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White matter hyperintensities as seen on brain T2-weighted magnetic resonance imaging are associated with varying degrees of
cognitive dysfunction in stroke, cerebral small vessel disease and dementia. The pathophysiological mechanisms within the white
matter accounting for cognitive dysfunction remain unclear. With the hypothesis that gliovascular interactions are impaired in
subjects with high burdens of white matter hyperintensities, we performed clinicopathological studies in post-stroke survivors, who
had exhibited greater frontal white matter hyperintensities volumes that predicted shorter time to dementia onset.
Histopathological methods were used to identify substrates in the white matter that would distinguish post-stroke demented
from post-stroke non-demented subjects. We focused on the reactive cell marker glial fibrillary acidic protein (GFAP) to study
the incidence and location of clasmatodendrosis, a morphological attribute of irreversibly injured astrocytes. In contrast to normal
appearing GFAP+ astrocytes, clasmatodendrocytes were swollen and had vacuolated cell bodies. Other markers such as aldehyde
dehydrogenase 1 family, member L1 (ALDH1L1) showed cytoplasmic disintegration of the astrocytes. Total GFAP+ cells in both
the frontal and temporal white matter were not greater in post-stroke demented versus post-stroke non-demented subjects.
However, the percentage of clasmatodendrocytes was increased by 42-fold in subjects with post-stroke demented compared to
post-stroke non-demented subjects (P = 0.026) and by 11-fold in older controls versus young controls (P50.023) in the frontal
white matter. High ratios of clasmotodendrocytes to total astrocytes in the frontal white matter were consistent with lower Mini-
Mental State Examination and the revised Cambridge Cognition Examination scores in post-stroke demented subjects. Double
immunofluorescent staining showed aberrant co-localization of aquaporin 4 (AQP4) in retracted GFAP+ astrocytes with disrupted
end-feet juxtaposed to microvessels. To explore whether this was associated with the disrupted gliovascular interactions or blood–
brain barrier damage, we assessed the co-localization of GFAP and AQP4 immunoreactivities in post-mortem brains from adult
baboons with cerebral hypoperfusive injury, induced by occlusion of three major vessels supplying blood to the brain. Analysis of
the frontal white matter in perfused brains from the animals surviving 1–28 days after occlusion revealed that the highest intensity
of fibrinogen immunoreactivity was at 14 days. At this survival time point, we also noted strikingly similar redistribution of AQP4
and GFAP+ astrocytes transformed into clasmatodendrocytes. Our findings suggest novel associations between irreversible astro-
cyte injury and disruption of gliovascular interactions at the blood–brain barrier in the frontal white matter and cognitive im-
pairment in elderly post-stroke survivors. We propose that clasmatodendrosis is another pathological substrate, linked to white
matter hyperintensities and frontal white matter changes, which may contribute to post-stroke or small vessel disease dementia.
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Introduction
Dementia develops in 25–30% of elderly people who sur-
vive after stroke (Savva and Stephan, 2010; Allan et al.,
2011). Various brain structure changes associated with
neurodegenerative dementias such as total cerebral
volume, medial temporal lobe atrophy and cortical thin-
ning, also relate to cognitive dysfunction in cerebrovascular
disease. However, the pathological substrates associated
with cognitive impairment or dementia in cerebrovascular
disease remain poorly deﬁned. White matter hyperintensi-
ties as seen on brain T2-weighted MRI have been linked to
varying degrees of cognitive impairment (Debette and
Markus, 2010). The prevalence and the volume of white
matter hyperintensities increase exponentially with age (de
Leeuw et al., 2001), and are associated with variable sever-
ity of executive dysfunction (DeCarli et al., 1995; Vataja
et al., 2003; Bolandzadeh et al., 2012). We previously re-
ported that in older stroke patients, cognitive processing
speed and performance as measures of attention are signiﬁ-
cantly associated with white matter hyperintensity volume,
particularly in the frontal lobe regions, whereas memory
impairment was associated with the volume of temporal
lobe white matter hyperintensities (Burton et al., 2004). It
has been widely proposed that many of the cognitive def-
icits in cerebrovascular dementia are attributed to disrup-
tion of the frontal-subcortical circuits (Kalaria and Ihara,
2013).
We have previously shown that myelin density in the
white matter was most reduced in vascular dementia com-
pared to Alzheimer’s disease and other less prevalent de-
mentias (Ihara et al., 2010). These observations are
consistent with the severity of white matter disease and
decreased ratios of myelin basic protein and proteolipid
protein in subjects with small vessel disease and vascular
dementia compared with Alzheimer’s disease and ageing
controls (Barker et al., 2013). In vascular dementia, the
vasoconstrictor endothelin 1 tended to be elevated, possibly
reﬂecting abnormal regulation of white matter perfusion
(Barker et al., 2014). However, the precise pathophysio-
logical relationships between white matter changes and
cognitive dysfunction are not well understood.
In addition to myelin, axonal and microvascular integrity
as well as glial cell reactivity have been of interest as pos-
sible substrates of the white matter that correlate with the
severity of white matter hyperintensities and cognitive im-
pairment. Astrocytes, as one of the fundamental glial cells
in brain tissue (Abbott et al., 2006), are important for
creating a homeostatic environment and providing energy
for oligodendrocytes and axons (Funfschilling et al., 2012).
During ischaemia, when acidosis and energy failure occurs,
astrocytes can undergo clasmatodendrosis, and cells
become amoeboid in shape (Penﬁeld, 1928; Friede and
van Houten, 1961). Clasmatodendrosis is further character-
ized by cytoplasmic swelling and vacuolation of the astro-
cyte soma, with beading and fragmentation of their
dendritic processes, leading to irreversible injury via an
autophagic process (Qin et al., 2010). The alterations in
cell morphology are directly related to changes in cell func-
tion (Hulse et al., 2001; Hinson et al., 2007).
Clasmatodendrosis was previously described in various
conditions including acute hypoxic-ischaemic injury (Gelot
et al., 2009), epilepsy (Kim et al., 2011), and neuromyelitis
optica (Tradtrantip et al., 2012; Misu et al., 2013). It was
also demonstrated in the white matter of patients with
Binswanger’s leukoencephalopathy and mixed dementia
(Alzheimer’s disease combined with cerebrovascular dis-
ease) (Tomimoto et al., 1996, 1997) and described in a
patient exhibiting severe white matter hyperintensities
with autopsy-conﬁrmed mixed dementia (Sahlas et al.,
2002) but not necessarily associated with demyelination
or neurodegeneration (Popescu et al., 2010). However,
clasmatodendrosis has not been evaluated in the develop-
ment of dementia in cerebrovascular disease.
With the hypothesis that gliovascular interactions are dis-
rupted in individuals who exhibit a high burden of white
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matter hyperintensity volume, we explored the incidence of
clasmatodendrosis in relation to the cerebral microvascula-
ture in the white matter of elderly stroke survivors, who
had developed dementia compared to those who remained
cognitively stable and older controls. To further test the
hypothesis and verify if the phenomenon was associated
with disruption of gliovascular interactions or breach of
the blood–brain barrier in the white matter (Wardlaw
et al., 2009), we evaluated perfused post-mortem brain
tissue from non-human primates subjected to cerebral
hypoperfusion.
Materials and methods
Subjects and dementia diagnoses
Stroke patients taking part in the white matter hyperintensities
imaging investigation were from a previously described cohort,
which was followed longitudinally (Allan et al., 2011). Patients
were comprehensively assessed at 3 months post-stroke using a
standardized battery comprising medical history, Mini-Mental
State Examination (MMSE) score, assessment of neurological
deﬁcits, blood screen and review of CT brain scan undertaken
at the time of stroke, and were excluded if they: (i) had sig-
niﬁcant physical illness and disabilities that precluded neuro-
psychological evaluation (e.g. visual impairment, aphasia,
hemiparesis affecting the hand used for writing); (ii) had a
diagnosis of dementia according to DSM-IIIR (Diagnostic
and Statistical Manual of Mental Disorders) criteria; or (iii)
declined to take part. Subjects underwent an annual clinical
and cognitive assessment. DSM-IIIR criteria were used because
they include a general deﬁnition for dementia, unlike DSM-IV,
which presumes aetiology, as we were interested in post-stroke
dementia regardless of cause. The total number of MRI scans
was limited by cost to 100, so not all subjects were ap-
proached. Eligible subjects were consecutively invited to have
an MRI scan until 106 had agreed. The analysis here is a
subset looking at frontal white matter hyperintensities as a
function of time to dementia or death (Table 1). The analysis
was performed in scans from 41 decliners, who developed de-
mentia and 65 stable post-stroke survivors. Following full ex-
planation and discussion of the study, patients gave their
consent to the evaluations, with additional assent from the
next of kin. Ethical approval and permission to progress this
study using donated human brain was granted by the
Newcastle and North Tyneside 1 Research Ethics Committee.
MRI acquisition and white matter
hyperintensity volumes
One hundred and six subjects were imaged using a 1.5T GE
Signa scanner (General Electric). Volume of white matter
hyperintensities was obtained from the baseline MRI images
(Fig. 1) using previously validated automated software
(Firbank et al., 2012). Brieﬂy, spm99 (http://www.ﬁl.ion.ucl.
ac.uk/spm) was used to segment the brain from the FLAIR
images. Volumes of white matter hyperintensities were then
determined by applying an intensity threshold of 1.45-times
the modal intensity for each slice to segment the white
matter hyperintensities. The accuracy of this was checked visu-
ally for each subject and the total white matter hyperintensities
volume in the whole brain was calculated. Values in Table 1
are white matter hyperintensities (in ml) for ease of interpret-
ation; however, for the statistical analysis, we calculated the
ratio of white matter hyperintensity volume to total brain
volume, and to produce normally distributed data we per-
formed log transformation. Subjects were followed up for a
mean of 4.0 (SD 2.5) years to last dementia assessment, and
5.9 (SD 2.3) years for deaths. All subjects (apart from two)
were followed-up until either death or 9 years after initiation
of the study. Of those whose ﬁnal status was ‘without demen-
tia’, 32 (74%) out of the 43 who died and 23 (64%) of the 36
still alive had dementia assessment within 1 year of their last
recorded vital status.
Neuropathological examination
Brains were retrieved from a total of 40 post-stroke survivors
who came to autopsy. Fourteen subjects, who were scanned in
life were included in this cohort (Table 2). In addition, we
analysed brains from elderly controls, who were age-matched
to subjects with post-stroke dementia (PSD) and post-stroke
non-demented subjects (PSND), and also a further group of
younger controls to demonstrate the effects of ageing alone.
Table 2 also provides the ﬁnal MMSE and the revised
Cambridge Cognition Examination (CAMCOG) battery
scores of the relevant subjects. Stroke survivors who did not
meet DSM-IIIR or IV criteria for dementia and had MMSE
scores 425 and CAMCOG scores 485 were designated as
‘post-stroke survivors with no dementia’. In the majority of
cases, bronchopneumonia was recorded as the cause of death.
Neuropathological assessment was carried out as described
previously using standardized protocols (Kalaria et al., 2004;
Ihara et al., 2010; Allan et al., 2011; Gemmell et al., 2012).
Macroscopic infarcts, detected by visual inspection while dis-
secting the brain, were subsequently conﬁrmed by light micros-
copy. Haematoxylin and eosin staining was used for
assessment of structural integrity and infarcts, Nissl and
Luxol fast blue staining for cellular patterns and myelin loss,
Bielschowsky’s silver impregnation and immunohistochemical
analysis of amyloid-b deposition using antibodies to amyloid-b
(4G8, 1:1000, Signet) for the Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD) rating of neuritic
plaques, Gallays for Braak staging of neuroﬁbrillary tangles.
Deposition of hyperphosphorylated tau with the AT8 antibody
(1:1000, Monoclonal Innogenetics) was further scored using
the semi-quantitative approach as described previously (Lace
et al., 2009). Vascular pathology scores were derived from the
presence of vascular lesions in brain areas, including the fron-
tal lobe at the level of the olfactory bulbs, temporal lobe at the
level of the anterior hippocampus, and basal ganglia at the
level of mamillary body. Lesions including arteriolosclerosis,
ﬁbrinoid necrosis, perivascular spacing and haemosiderin leak-
age and tissue changes including lacunes, microinfarcts, micro-
haemorrhages and myelin loss in the deep and juxtacortical
white matter, and cortical micro (50.5 cm) and large
(40.5 cm) infarcts were recorded with increasing severity re-
sulting in greater scores (Deramecourt et al., 2012).
Tissues from control subjects had occasional ageing-related
pathology and were classiﬁed having ‘no pathological diagno-
sis’ (Table 2). Tissue showing any evidence of infarction was
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Figure 1 Frontal white matter hyperintensities and associated pathology in stroke survivors. (A) Survival curves show progression
time to dementia by the presence of frontal white matter hyperintensities volume in non-demented (PSND, top) and demented (PSD, bottom)
subjects. The mean number of days from stroke to dementia in the non-demented and DSM IV demented groups was 1483  922 and 1059  676
(P = 0.001). (B) MRI (a and e) in life and coronal sections (b–d and f–h) demonstrate the extent of differential white matter changes in subjects
with PSND (b–d) and PSD (f–h) from the cohort described inA. [B(a and e)] Typical white matter hyperintensity volume differences on MRI with
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excluded. Patients with any type of dementing illness were also
excluded. In PSD cases, a clinical diagnosis of vascular demen-
tia was made when there were multiple or cystic infarcts, lacu-
nae, microinfarcts and small vessel disease, and Braak stage
4IV (Kalaria et al., 2004). Mixed dementia was classiﬁed
when there was signiﬁcant vascular pathology coupled with
appropriate levels of neuroﬁbrillary pathology (Braak staging)
and neuritic plaques (CERAD rated) (Kalaria et al., 2004).
Three vessel occlusion model and
neuropathological analysis in
non-human primates
Post-mortem brain tissues were obtained from adult baboons
(Papio anubis) weighing 16–20 kg (7–12 years old), housed at
the Institute of Primate Research, National Museums of
Kenya. These non-human primates used widely for stroke re-
search also develop Alzheimer’s disease pathology (Ndung’u
et al., 2012), were part of a study to understand the sequelae
of brain changes during cerebral hypoperfusion. This study
was performed in collaboration with Kyoto University (Y.H.,
K.W., Y.O. and M.I.). The animals were subjected to perman-
ent occlusion of both the internal carotid arteries and the left
vertebral artery for survival periods of 1, 3, 7, 14, 21 and 28
days (n = 4–7 each group). Following such three-vessel occlu-
sion, temporary mild hemiparesis was evident in all the ani-
mals. Animals were euthanized on the designated day and the
brains (200–300 g) were retrieved after perfusion ﬁxation.
Subsequent to further immersion ﬁxation period of 4–6
weeks, 1-cm thick coronal slices of the brain were processed
for extensive histopathological analysis and quantitative evalu-
ation in the same manner as the human post-mortem cases
(Ihara et al., 2010; Deramecourt et al., 2012). We used routine
tinctorial stains and immunohistochemistry on 10-mm thick
sections of the whole coronal face to assess pathology in the
white matter. This included evaluation for changes in myelin
(Luxol fast blue), endothelial integrity (haematoxylin and
eosin, glucose transporter type 1 (GLUT1, encoded by
SLC2A1), basement membrane (collagen IV, COL4), the
Figure 1 Continued
FLAIR in PSND (a) and PSD (e) subjects. Examples are from females aged 86 and 90 years. [B(b, c, f and g)] Coronal sections from the magnetic
resonance scanned cases stained with Luxol fast blue and haematoxylin and eosin. Diffuse myelin changes are more evident in the PSD coronal
sections. [B(d and h)] Adjacent sections from the same cases stained for fibrinogen immunoreactivity. [B(h)] shows diffuse immunoreactivity and
also demonstrates in astrocytes blood–brain barrier leakage of proteins. The location of coronal sections in B(b, c, f and g) are shown by the
white line in the axial MR scans in B(a and e). Images in B(d and h) are from the frontal white matter areas represented by boxes in the
haematoxylin and eosin-stained sections B(c and g). Scale bar = 10 mm. WMH = white matter hyperintensities.
Table 1 Neuroimaging study subject characteristics and survival to dementia predictors stratified by age in a
multivariate cox model
Age at baseline 79.8 (4.1) n = 106
Gender F:M 57:49
Deceased during follow-up 60 (57%)
Developed dementia during follow-up 27 (25%)
MMSE 26.2 (2.7)
CAMCOG-R 84.4 (8.5)
MTA 2.7 (1.8)
White matter hyperintensity, ml 2.1 (1.8)
Total brain volume 1009 (82.4)
Oxford Stroke Classification (LACS/PACS/TACS/POCS/unknown) 35/42/5/17/7
HR (95% CI) P-value
Significant neuroimaging predictor
MTA 1.40 (1.07 to 1.85) 0.016
Log (frontal white matter hyperintensities / total brain volume) 1.88 (1.05 to 3.36) 0.034
AIREN bilateral thalamic lesions 9.18 (2.36 to 35.63) 0.001
Significant neuroimaging predictor + cognitive score
MTA 1.32 (1.00 to 1.74) 0.054
Log (frontal white matter hyperintensities / total brain volume) 1.68 (0.92 to 3.05) 0.09
AIREN bilateral thalamic lesions 4.58 (1.19 to 17.70) 0.027
CAMCOG-R 0.93 (0.89 to 0.98) 0.004
Oxford community stroke project (OCSP) classification: there were no significant differences between stroke territory distributions between PSND and PSD cases (P4 0.05).
CAMCOG = Cambridge Assessment for mental and cognition; LACS = lacunar stroke; na = not available; PACS = partial anterior circulation stroke; POCS = posterior circulation
stroke; TACS = total anterior circulation stroke; AIREN = relevant imaging change meets imaging criteria as specified in the National Institute of Neurological Disorders and Stroke
Association/Internationale pour la Recherche et al’ Enseignement en Neurosciences (NINDS/AIREN) criteria; CAMCOG-R = Cambridge Cognitive Assessment-revised;
GDS = Geriatric Depression 15 point scale; MTA = medial temporal lobe atrophy rating; MMSE = Mini-Mental State Examination; TIA = transient ischaemic attack.
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blood–brain barrier (ﬁbrinogen), the key water channel protein
(AQP4) and astrocytes (GFAP). The Institute of Primate
Research (IPR) internal review board of the National
Museums granted ethical approval and permission for this
entire study.
Immunohistochemistry and
immunofluorescent labelling
Ten- or 6-mm thick parafﬁn wax embedded coronal sections
from PSND, PSD and non-stroke controls were immunos-
tained with various primary monoclonal or polyclonal antibo-
dies: rabbit anti-GFAP antibody (1:1000, Z0334, Dako),
mouse anti-GFAP (1:50, clone 6F2, M0761, Dako), aldehyde
dehydrogenase 1 family, member L1 (ALDH1L1; 1:100 in
0.1% TrionTM X-100–PBS for immunoﬂuorescence, clone
7G8, mouse antibody, 14-9595, eBioscience), aquaporin
4 (AQP4; 1:50, rabbit antibody, 16473-1-AP, Proteintech),
Delta Like-1 (DLL1; 1:1000, goat antibody, Ab# 76655
Abcam), LC3 (autophagic vacuoles; 1:100, rabbit antibody,
AP1801a Abgent), Poly (ADP-ribose) polymers (PARP1 of
2nd Zinc ﬁnger of DNA binding domain, 1:30, polyclonal
rabbit, Prof. Alex Burkle, University of Konstanz, Germany)
and ﬁbrinogen (1:2000, rabbit antibody, A0080, Dako). Tissue
sections ﬁrst underwent antigen retrieval by heating in the
microwave with citrate buffer for 12min before being
quenched with Tris-buffered saline and 3% hydrogen perox-
ide. Sections were then blocked with serum derived from the
species in which the secondary antibody was generated, before
being immunostained with the primary antibody overnight
at 4C.
Standard colour immunohistochemistry was performed using
the Vectastain ABC System. Quantiﬁcation was performed fol-
lowing the general pattern we established previously for either
parenchymal or cellular protein immunoreactivity (Ihara et al.,
2010; Foster et al., 2014). Brieﬂy for GFAP+ cells, at least 20
images were acquired randomly from areas of the deep white
matter in coronal sections (Fig. 2), using a Leitz DIALUX 20
brightﬁeld microscope coupled to a lumenera inﬁnity digital
camera at 6.3 magniﬁcation. Using ImageJ, the total
GFAP+ cells and cells showing features of clasmatodendrosis
(swollen cell body and beaded processes) were counted from
both frontal and temporal deep white matter in each case, with
the percentage of clasmatodendrotic astroglia calculated and
expressed as a ratio. To verify that only astrocytic cells were
targeted, we determined that GFAP cell counts per 0.5mm2
correlated positively with GFAP staining per unit area
Table 2 Pathological study subject demographics and clinical features
Group Young controls Old controls PSND PSD
n 10 15 23 17
Age (years)* 61.1  2.3 84.2  2.6 84.0  0.8 87.6  1.4
Gender (F:M) 5:2 13:2 8:15 10:7
PMD (h) 46  9 39  6 37  4 39  6
Clinical and psychometric features
MMSE (0–30)* Na na 27.3  0.3 16.5  1.2
Total CAMCOG (0–106)* na na 88.8 (83–98) 62.5 (24–80)
Time from baseline to death (months) – – 63.5 (22) 64.4 (14)
Memory subscore (/27)* – – 21.4 (2.8) 15 (4.3)
Executive function subscore (/28)* – – 16.6 (1.2) 11.1 (1.9)
Clinical Dementia Rating (CDR)* – – 0.1  0.4 1.28 (0.25)
Hemisphere with visible change or not on CT; None, right, left, both – – 14, 3, 2, 4 8, 4, 1, 4
OCSP stroke classification LACS, PACS, POCS, TACS – – 13, 4, 2, 4 8, 4, 1, 4
Pathological markers
Braak Staging rangea 0–I I–III I–IV I–IV
Tau (AT-8) Score 0–6 (range)b – 1.3 (1–3) 1 (1) 1.3 (1–3)
CERAD Score rangec – 1–2 1–2 1––3
Vascular pathology score (range)d – 8.1 (8–10) 13.5 (13–14) 13.3 (9–17)
White matter score (SEM)e – 1.5 (0.3) 2.5 (0.4) 2.4 (0.4)
Myelin index (SEM)e – 25 (2) 30 (4) 34 (3)
Sclerotic index (SEM)e – 0.40 (0.03) 0.44 (0.02) 0.40 (0.01)
Perivascular spacing (SEM)e – 83 (8.6) 82 (4.6) 82 (5.2)
Numbers represent mean values (2 SEM) and where given with the range of values in parentheses. The causes of death included bronchopneumonia, cardiac arrest and carcinoma
with no particular distribution in any group. The time period (weeks) of tissue fixation was in range 8–40 weeks for all the cases. There was no pathological diagnosis in young or old
controls.
aBraak staging in 490% of the cases was below III. None of the cases had neurofibrillary pathology above stage V (Kalaria et al., 2004).
bHyperphosphorylated Tau scores were derived by immunostaining sections with AT-8 antibody using a visual rating score from 0 to 6 in order of severity. AT8 immunoreactivity was
not significantly different between PSND and PSD.
cCERAD scores were determined as 1 = sparse, 2 = moderate and 3 = severe.
dVascular pathology scores were derived as described previously (Deramecourt et al., 2012).
eData for the frontal lobe only.
*Significance: P5 0.05 between young and older controls and between the PSND and PSD groups.
CERAD = Consortium to Establish a Registry for Alzheimer’s disease score; n = number; na = not available; OCSP = Oxford Community Stroke Project; PMD = post-mortem delay;
LACS = lacunar stroke; PACS = partial anterior circulation stroke; POCS = posterior circulation stroke; TACS = total anterior circulation stroke.
Clasmatodendrosis in post-stroke dementia BRAIN 2016: 139; 242–258 | 247
Figure 2 Distribution of GFAP+ clasmatodendrocytes in the deep white matter regions of post-stroke survivors. (A–C) Panels
show normal appearance of GFAP+ astrocytes in the immediate superficial layers of the white matter (A), retracted astrocytes at mid-level (B)
and clasmatodendrocytes in the deep white matter, with a particularly high concentration at the level of the anterior horn of the lateral ventricles
(C). Insets in A and C show a higher magnification of the different forms of GFAP+ astrocytes predominant in A and C, respectively. In C inset,
cell vacuolation is evident. Boxes 1–3 inD delineate location of images (A–C), demonstrating the distribution of GFAP+ cells from the immediate
subcortical layer to the deep white matter. Illustrative coronal sections (E–H) shows the distribution of clasmatodendrocyte densities (brown
dots) in the white matter regions at different coronal levels incorporating the frontal, temporal and parietal lobes. Box in F represents
approximate location of image D. Scale bars = 100 mm (A–C); 20mm (insets). WM = white matter.
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( = 0.754, P5 0.001). We also showed there was a positive
correlation between the frontal and temporal total GFAP
immunoreactivities ( = 0.500, P = 0.003) (plots not shown).
For immunoﬂuorescent labelling, the primary antibodies
were removed and sections washed with PBS prior to incuba-
tion at room temperature for 1 h with goat anti-mouse second-
ary antibody, Dylight 650 conjugated (1:200, 84545, Thermo
Scientiﬁc) and goat anti-rabbit secondary antibody, Texas Red
conjugated (1:200, T2767, Life Technologies). Sections were
counterstained and mounted with DAPI incorporated mount-
ing medium (Dako). A Leica TCS SP2 UV AOBS MP (upright
confocal microscope) and a Life Technologies EVOS FL (LED)
ﬂuorescent microscope were used for image capture.
White matter rating scale and myelin
density
Severity of white matter damage and myelin density was as-
sessed by examining Luxol fast blue and haematoxylin and
eosin stained sections using the Zeiss Axioplan 2 research
grade microscope at 5 and 10 magniﬁcation. The myelin
index was determined by assessing Luxol fast blue stained sec-
tions (Ihara et al., 2010). To achieve this the entire white
matter region in 10-mm Luxol fast blue-stained sections of
the whole coronal face at the level of Brodmann area (BA) 9
in the frontal lobe and BA 36 in the temporal lobe per
Newcastle Brain Reference Map (Perry and Oakley, 1993)
was outlined automatically using the wand tool on Image
Pro software (Mediacybernetics, USA) as described previously
(Ihara et al., 2010). Digital images of the white matter area
were then converted to grey scales, corresponding to the stain-
ing intensity, from point 0–127 (0, white; 255, black). The
intensity proﬁle was then divided into four quartiles (the ﬁrst
quartile 0–29, the second 30–62, the third 63–94, and the
fourth 95–127) and the per cent area for each quartile was
calculated. The median grey level of each quartile (14.5, 46.0,
78.5, and 111.0), an estimate for the staining intensity, was
then multiplied by % area/100 in each quartile, which gave the
total myelin index. Highest myelin index value indicates no
myelin loss, whilst lowest myelin index indicates total myelin
loss and the levels inbetween indicate varying degrees of
myelin density. We also veriﬁed the degrees of myelin density
(normal, mild, moderate and severe) by imaging adjacent
haematoxylin and eosin stained sections in a subset of cases
(n = 35). These data together with accumulation of degraded
myelin basic protein showed remarkable consistency in the
assessment of myelin loss between Luxol fast blue and haema-
toxylin and eosin (Sjobeck et al., 2005; Ihara et al., 2010;
Smallwood et al., 2012).
The intensity of ﬁbrinogen immunoreactivity across the
whole white matter in coronal sections taken from identical
levels (equivalent to BA 9 at level of precentral gyrus) from
each animal, was determined by ImageJ integrated optical
density analysis (Kalaria et al., 2012). The ﬁbrinogen immu-
noreactivity represented an arbitrary scale determined from the
digital images (as above). Images from sham were set at a
value of 10 on the scale and all groups were normalized to
the sham group.
To assess the degrees of arteriolosclerosis, the sclerotic index
(SI) and perivascular spaces were quantiﬁed in the white
matter of the brains, inclusive of controls. The Vascal
programme (Yamamoto et al., 2009) was used to measure
the external diameter (Dext) of the vessel and the diameter
(Dint) of the lumen. These values were then used to calculate
the sclerotic index and perivascular space for each vessel using
the equation: SI = 1 (Dint/Dext).
Cellular morphometry and
microvascular markers
For glial cell morphometry, 30-mm thick parafﬁn sections were
stained with cresyl fast violet (Khundakar et al., 2009) and the
cell density was determined using the optical dissector method
under a Zeiss Axioplan Photomicroscope. Cells in the cortical
layers or white matter regions of interest were distinguished by
their shape and subtle features (Khundakar et al., 2009). Glial
cells were identiﬁed by their spherical shape, absence of Nissl
staining in the cytoplasm and the heterogenous arrangement of
chromatin in the nucleus. Neurons were identiﬁed by the pres-
ence of a Nissl-stained cytoplasm, pale nucleus and single iden-
tiﬁable nucleolus in cells. The reference area was mapped out
using a 2.5  objective and Visiopharm Integrator System
(VIS) software. In pilot studies, we determined that 40
frames in up to three sections from each case comprising
4100 cells per case had to be assessed to reduce the sampling
error or the coefﬁcient of error value (deﬁned as the standard
error of the mean of repeated estimates divided by the mean)
to a satisfactory level, P5 0.05 (Burke et al., 2014; Foster
et al., 2014).
For the microvascular markers, 20-mm thick serial sections
were immunostained with antibodies to GLUT1 (1:200,
ThermoScientiﬁc UK), a marker for endothelial cells in micro-
vessels. GLUT1 immunostained microvessel proﬁles were then
quantiﬁed in whole coronal sections as described previously
(Burke et al., 2014). As above, frontal lobe sections were ana-
lysed at the level of the olfactory bulbs incorporating BA 9 and
the temporal lobe sections at the level of the anterior hippo-
campus and BA 36 per Newcastle Brain Map (Perry and
Oakley, 1993).
Except for the neuropathological examination (by T.M.P
and R.K) described above, all of the morphological analyses
were always performed under operator blinded conditions.
Samples were appropriately identiﬁed with coded sequential
numbers. We also repeated all staining at least twice and
used at least three sections for staining throughout (Foster
et al., 2014). In addition, at least two of each positive and
negative controls were included to monitor the quality of
staining.
Statistical analysis
Statistical analysis was carried out using SPSS Version 21
with the level of signiﬁcance set at P5 0.05. Normal distri-
bution of values was ﬁrst tested using the Shapiro-Wilk test.
In previous analyses, data found to be not normally distrib-
uted were analysed using non-parametric methods. Group
means such as PSND, PSD and controls were compared
using ANOVA with post hoc Tukey tests for normal data
or Kruskall-Wallis, Newman-Keuls and the Mann-Whitney
U-tests for non-normally distributed values e.g. differences
between pathological variables and total GFAP + cells or
the ratios of clasmatodendrocytes in different groups.
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Spearman’s rank  correlation was used to assess correl-
ations between clinical and neuropsychometric variables or
speciﬁc protein immunoreactivity measures and microvascu-
lar changes.
To examine the associations between exposure to putative
risk factors for dementia, Cox proportional regression analyses
were used to obtain univariate proportional hazard ratios for
each risk factor, using time (days) from index stroke to demen-
tia as the dependent variable. If a patient died, data were right
censored. The date of onset of dementia was assumed to be at
the midpoint between the two assessments where dementia
status changed. Hazard ratios were given according to pres-
ence or absence of the risk factor, or per point on quantitative
scales, as appropriate. Following identiﬁcation in univariate
models, frontal white matter hyperintensity volume and other
signiﬁcant predictors of dementia were entered into a multi-
variate Cox regression model.
Results
Frontal lobe white matter hyperin-
tensity as a predictor of survival to
dementia
The frontal lobe white matter hyperintensity volume was
determined in 106 subjects scanned during life. Figure 1A
shows the survival curves to dementia in non-demented
subjects, who remained stable and those who declined to
dementia after stroke. Univariate Cox survival analysis for
time to dementia indicated volume of white matter hyper-
intensities was a signiﬁcant neuroimaging predictor of
shorter time to dementia onset (Table 1). The multivariate
model controlling for age also showed frontal white matter
hyperintensity volume as an independent predictor of sur-
vival to dementia [P = 0.034, Hazard ratio 95% 1.88 (1.05
to 3.36)], indicating increased white matter hyperintensities
volume in those who developed dementia. However, when
we included the cognitive scores there was only a trend for
the frontal white matter hyperintensity volume to predict
survival to dementia (Table 1). Of these post-stroke sur-
vivors who had MRI in life, 14 stable (PSND) and de-
cliners, who developed post-stroke dementia (PSD) came
to autopsy. Pathological examination showed typical vas-
cular and ischaemic stroke related tissue changes. The total
vascular pathology scores between all the PSND and PSD
were not signiﬁcantly different (Table 2).
Frontal lobe white matter astrocytes
in post-stroke survivors
To explain the differential ﬁndings of the frontal white
matter hyperintensity volumes, we attempted identiﬁcation
of markers to delineate the two groups. We hypothesized
that reactive cells of the gliomicrovascular unit or myelin
are more affected in the frontal white matter of PSD com-
pared to PSND subjects. We ﬁrst noted that there was
increased diffuse ﬁbrinogen immunoreactivity in the frontal
white matter in PSD compared to PSND subjects [Fig. 1B(d
and h)]. The ﬁbrinogen immunoreactivity in PSD subjects
was frequently associated with normal-appearing and
rounded astrocytic cells [Fig. 1B(h)]. Using light and ﬂuor-
escent microscopy, we assessed GFAP+ astrocytes in cor-
onal sections throughout the brain with emphasis on the
frontal and temporal white matter. We observed GFAP+
astrocytes of various shapes and sizes (Fig. 2) in both
frontal and temporal white matter. As expected ‘normal’
GFAP+ astrocytes (Fig. 2A) had numerous long, ﬁne pro-
cesses. However, in the deeper layers of the white matter
we noted GFAP+ clasmatodendrotic cells with swollen and
vacuolated appearance and many bearing isolated beaded
processes (Fig. 2C). Examination of complete coronal sec-
tions incorporating the whole of the white matter revealed
gradients of normal to clasmatodendrotic astrocytes
(Fig. 2D). The deeper layers exhibited many more clasma-
todendrocytes than the superﬁcial layers with a high con-
centration near the ventricles. Mapping of coronal sections
(Fig. 2E–H) from the four lobes of PSD and PSND subjects
indicated that the highest concentration of clasmatodendro-
cytes was apparent in the frontal lobe within the deep
white matter at the level of the middle frontal gyrus and
anterior horn of the lateral ventricles and incorporating the
centrum semiovale region. Observations from all the 40
post-stroke brains (Table 2) indicated that the density of
clasmatodendrocytes found in the subcortical regions
were in following decreasing order: frontal white
matter4 prefrontal white matter5 temporal white mat-
ter5 parietal white matter4 lenticular nuclei regions.
Clasmatodendrocytes in the external or internal capsules
were seldom present.
Quantiﬁcation of the total GFAP+ cells in the white
matter and the percentage of clasmatodendrocytic cells
with swollen cell bodies and beaded processes revealed dis-
similarities between the PSND and PSD groups and com-
pared to young and older controls (Fig. 3). There were no
signiﬁcant differences between PSND and PSD groups with
respect to the total GFAP+ cells in both frontal and tem-
poral deep white matter (P = 0.850 and P = 0.745, respect-
ively). However, the presence of stroke increased the
number of astrocytes as shown by the increased total
number of GFAP+ cells in the PSND and PSD groups in
the temporal white matter compared to the similar age
controls (Fig. 3A; P = 0.007 and P = 0.018, respectively).
We also found an ageing effect in that the older controls
had fewer astrocytes in both the frontal (P = 0.04) and tem-
poral white matter (P = 0.007) compared to younger con-
trols (Fig. 3A). These changes were restricted to the frontal
white matter rather than the grey matter. The 3D morpho-
metric analyses showed that glial cell density in the neocor-
tex (layers III and V) was not changed between PSND and
PSD subjects (P4 0.05). There was also paucity of clasma-
todendrosis in the neocortex.
Most remarkably, we observed that the percentage of
clasmatodendrocytes in the frontal white matter was
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signiﬁcantly greater (by 100%) in the PSD than in the PSND
group (Fig. 3B; median = 0.24 for PSD, median = 0.02 for
PSND, P = 0.030), but a similar increase was not evident in
the temporal white matter (median = 0.03 for PSD and 0.04
for PSND, P = 0.725). In comparison with older age-
matched controls (median = 0.015 and 0.002 for frontal
and temporal white matter, respectively), there was more
clasmatodendrosis in the frontal white matter of PSD
(P = 0.082), which was not apparent in the PSND
group (Fig. 3B). We also found a striking difference be-
tween older and younger controls (P = 0.023), with
almost no presence of clasmatodendrocytes in either the
frontal or temporal white matter in young controls.
Multiple regression analysis for dependent variable (par-
ameter from cognitive test), with independent variables
(age, frontal or temporal white matter GFAP + cell num-
bers, ratio of clasmatodendrosis) performed for PSND
and PSD patients, showed weak inverse correlations
with various cognitive function tests including MMSE
( = 0.355, P = 0.024), CAMCOG ( = 0.348, P = 0.028)
and total memory ( = 0.338, P = 0.033) scores as a func-
tion of age.
To exclude possible post-mortem effects on the occur-
rence of clasmatodendrosis, subjects with mild (510%)
and severe (510%) clasmatodendrosis were divided into
two separate groups. There were no statistical differences
in post-mortem delay (h) between cases with mild and
severe clasmatodendrosis (Supplementary Table 1). There
were more cases with severe clasmatodendrosis in the
PSD group than in the PSND and control groups. In add-
ition, the presence of clasmatodendrosis was not related to
tissue ﬁxation time or with the age or gender of the
subjects.
Double immunoﬂuorescent staining showed co-localization
of GFAP and AQP4 in astrocytes (Fig. 4). In the areas with
normal GFAP staining, AQP4 displayed an evenly distribu-
ted pattern with punctate reactivity within the astrocytic
end-feet. In areas of clasmatodendrosis, AQP4 was aggre-
gated in dense peripheral cellular deposits at the edge of
rounded or swollen GFAP+ cells (Fig. 4A). We also noted
transitional forms of GFAP+ cells or astrocytes where they
exhibited reduced processes and cell body swelling (Fig. 4A).
The disintegration of the GFAP+ cells was further evident in
astrocytes immunolabelled with ALDH1L1 antibodies.
ALDH1L1 as a cytoplasmic marker showed the differential
disintegration of the clasmatodendrocytes. The cytoplasmic
structure was disrupted in more cells with soma vacuolation
in contrast to the remnant GFAP immunoreactivity in cyto-
skeletal proteins (Fig. 4B). In subsequent experiments, we
showed that clasmatodendrocytes were also immunoreactive
for another marker, DLL1, which labelled most astrocytes.
Consistent with the autophagic mode of cell death, we found
that clasmatodendrocytes expressed PARP1 and LC3
immunoreactivities (Supplementary Fig. 1).
We further showed that the white matter microvessel or
capillaries were denuded of AQP4 immunoreactive astro-
cytic end-feet. This was readily seen in sections double
immunolabelled with AQP4 and COL4, particularly in
the PSD cases (Fig. 5). We noted that numerous capillaries
exhibited absence of astrocytic end-feet that was most con-
spicuous in areas of ﬁbrinogen immunoreactivity in subjects
with PSD.
In additional experiments, we also found that white matter
damage severity score correlated positively with the vascular
Figure 3 Quantification of GFAP+ cell numbers in the
frontal and temporal white matter in controls, PSND and
PSD subjects. (A) Box plots show total GFAP + astrocytes in the
frontal and temporal white matter. (B) Box plots show ratios of the
number of clasmatodendrocytes to total cells in the two white
matter regions. The y-axis values are 100. Number of samples for
each group are given in Table 2. The analysis was performed in
duplicate and gave similar results. *Significance: frontal white matter
total GFAP, young Control versus Control P = 0.04; temporal white
matter total GFAP, young Control versus Control P = 0.007,
Control versus PSND P = 0.007, Control versus PSND P = 0.018;
frontal white matter ratios GFAP, young Control versus Control
P = 0.023, Control versus PSD P = 0.033, PSND versus PSD
P = 0.03. (Mann-Whitney U-test) between the groups.
Ycontrol = young controls. Control represents age-matched
subjects to all groups except young controls. WM = white matter.
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score ( = 0.674, P5 0.001) but inversely with the myelin
index ( = 0.750, P50.001). Higher myelin index meant
better preserved myelin, as the index in this context is a meas-
ure of normal myelin (Ihara et al., 2010). The myelin index
was relatively higher in the control compared to PSND and
PSD groups in the frontal white matter, and the variation
showed a trend towards signiﬁcance (P = 0.069, Kruskal–
Wallis Test). The difference in myelin index between controls
Figure 4 Transformation of GFAP+ cells in the deep white matter in relation to microvessels. (A) Triple immunofluorescent
staining of GFAP (Cy5, Dylight 650 shown in green), AQP4 (Texas Red, shown in red) and DAPI for astrocytes and their processes. A(a1–4) is
from a PSND case; A(b1–4) is from a PSD case. A(c) AQP4 staining is mainly in the end-feet of astrocytes, frequently outlining a vessel (V). A(d)
shows an astrocyte with intermediate level of pathology: AQP4 immunostaining is also seen along the process and in the cellular membrane (white
arrow). A(d) Area outlined in a4. A(e) Higher magnification of area outlined in b4, demonstrates AQP4 is aggregated in dense peripheral cellular
deposits, at the periphery of the GFAP stained swollen astrocyte. A(f) Another example of astrocytes with GFAP stained swollen bodies and
fragmented processes, and demonstrates that AQP4 is located at the edge of cell bodies of retracted astrocytes (white arrows). A(d–f) The
progressive degenerative change or transition of the astrocytes. DAPI was used for nuclear counterstaining, which is eventually lost from the
astrocytes. (B) GFAP and ALDH1L1 immunoreactivities in clasmatodendrocytes in the deep white matter in a PSD subject. B(a–d)
Clasmatodendrocytes representing degenerating GFAP+ cells (arrows in b) lacking cytoplasmic ALDH1L1 reactivity. Scale bars in A (both in b4
and f) = 20mm and in B = 25mm.
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and the pathological groups (PSND, PSD) was surprisingly
lower than expected in both frontal and temporal white
matter, possibly due to a signiﬁcant amount of white matter
disease in the control group.
Blood–brain barrier integrity and
presence of clasmatodendrocytes in
frontal white matter in a non-human
primate model
To demonstrate that the phenomenon of clasmatodendrosis
occurring in white matter was associated with blood–brain
barrier changes and not a consequence of antemortem or
post-mortem modiﬁcation within the brain tissue, sections
from baboons subjected to cerebral hypoperfusion by three-
vessel occlusion were immunolabelled with antibodies to
ﬁbrinogen, GFAP and AQP4 (Fig. 6). In these series of
experiments, we ﬁrst quantiﬁed ﬁbrinogen immunoreactiv-
ity in the frontal white matter incorporating the equivalent
region of interest as in the PSD subjects. Analysis at
different periods of survival after three-vessel occlusion
showed that the greatest amount of ﬁbrinogen immunor-
eactivity was evident in 14-day animals. Fibrinogen immu-
noreactivity was signiﬁcantly increased at 14 days
compared to animals that survived 1 day after the occlusion
as well as the sham operated animals (Fig. 6A). These ob-
servations were consistent with the development of severe
white matter changes at 14 days after three-vessel occlu-
sion, predominantly in the deep white matter
(Supplementary Fig. 2). Using double immunoﬂuorescent
methods as with human post-mortem tissue (Fig. 6B), we
analysed a series of adjacent coronal sections from the
baboon brains. In the 14 day animals, remarkably we
found similar distribution of GFAP+ clasmatodendrocytes
with the characteristic AQP4 immunoreactivity at the edge
of the retracted cell bodies (Fig. 6B). This phenomenon was
not evident in the sham or 1 day animals and as in human
cases, there were no apparent white matter infarcts or is-
chaemic lesions in the vicinity of the clasmatodendrocytes.
Furthermore, the white matter changes were associated
with myelin loss, collapsed and degenerated microvessels
Figure 5 Redistribution of AQP4 from COL4 labelled microvessels and capillaries in the deep white matter in PSD. (A–C)
Panels show a AQP4 and COL4 labelled capillary in deep white matter of a PSND case demonstrating localization of AQP4 immunoreactivity in
the vessel wall (C). (D–F and insets) show lack of co-localization of AQP4 and COL4 in regions where clasmatodendrocytes were found. The
disrupted distribution of AQP4 is evident in F (arrow). Scale bar = 25mm.
Clasmatodendrosis in post-stroke dementia BRAIN 2016: 139; 242–258 | 253
labelled with endothelial (GLUT1) and basement mem-
brane (COL4) markers at 14 days after three-vessel
occlusion (Supplementary Fig. 3). The subsequent reduction
in ﬁbrinogen immunoreactivity and the lack of
clasmatodendrocytes (Fig. 6) together with increases in
immunoreactivities of the GLUT1 and COL4 in capillaries
within the frontal white matter beyond 14 days were con-
sistent with recovery of the patency or the reconstruction of
Figure 6 Integrity of the blood–brain barrier and presence of clasmatodendrocytes in the frontal white matter in a non-human
primate model of cerebral hypoperfusion. [A(a)] Quantification of fibrinogen reactivity in the frontal white matter of adult baboons
subjected to three-vessel occlusion (3VO). Brain images [A(b and c)] within the graph show the approximate coronal level of sampling for
immunofluorescent staining. Each time point denotes the mean level of fibrinogen from n = 4–7 animals and these results were obtained from
both hemispheres. There were no differences between the right and left hemispheres. ANOVA showed that there was a high variation in
fibrinogen immunoreactivity across all time points (P5 0.01). *Significance P5 0.05 compared to 1 day and sham groups. [B(a–c)] Astrocytes
from the frontal white matter of a sham animal, demonstrating normal distribution of GFAP [B(a)] and AQP4 [B(b)], with no sign of abnorm-
alities. B(c) is the merged image of B(a and b). Arrows denote AQP4 around periphery of blood vessel (V). [B(d–f)] Astrocytes in white matter
of an animal after 14 days of three-vessel occlusion, demonstrating clasmatodendrosis of the astrocytes immunolabelled with GFAP [B(d)] and an
abnormal distribution of AQP4 [B(e)]. B(f) A merged image of B(d and e). The inset shows high magnification of a clasmatodendrocyte identified
in B(f) (arrow) with typical peripheral distribution of AQP4 on the cell body. Scale bar = 50 mm; inset (f) = 20mm.
254 | BRAIN 2016: 139; 242–258 A. Chen et al.
the microvasculature to establish tissue perfusion
(Supplementary Fig. 3).
Discussion
Our study provides strong evidence for another patho-
logical substrate which contributes to the development of
dementia in post-stroke survivors, most of whom had vas-
cular dementia. We found highly increased degeneration of
astrocytes in PSD subjects who had greater more conﬂuent
white matter hyperintensities volumes. Clasmatodendrosis
was particularly prominent in the deep white matter of
the frontal lobe. Whereas markers of both myelin and
axon damage including the myelin index and immunoreac-
tivities of degenerated myelin basic protein, amyloid pre-
cursor protein and SMI32 in the white matter (Akinyemi,
2014; Foster et al., 2014) tended to be increased in the PSD
compared to the PSND subjects, quantiﬁcation of clasma-
todendrosis clearly separated the post-stroke stable from
those who developed dementia. The experimental design
of the study also allowed us to demonstrate that the
observed clasmatodendrosis was not necessarily associated
with peri-infarct regions (as we avoided these) but largely
within the deep white matter undergoing rarefaction both
in human and non-human primate brains. Our ﬁndings
suggest that clasmatodendrosis is a pathological gauge for
disruption of gliovascular interactions (Abbott et al., 2006)
likely instigated by underlying blood–brain barrier abnorm-
alities in the deep white matter of the frontal lobe. We
propose that this is an important factor, which explains
the association between white matter hyperintensities and
cognitive dysfunction in stroke survivors, cerebral small
vessel disease and vascular dementia. The ﬁndings are con-
sistent with previous observational studies indicating the
presence of clasmatodendrosis in dementing disorders
with white matter pathology (Tomimoto et al., 1996;
Sahlas et al., 2002).
Clasmatodendrosis may occur during different condi-
tions. Both neuromyelitis optica and central pontine myeli-
nolysis are primary astrocytopathies with secondary
demyelination. Clasmatodendrosis in the absence of demye-
lination or axonal degeneration is one of the six different
lesion types described in neuromyelitis optica (Misu et al.,
2013). Another type occurs with a variable degree of astro-
cyte clasmatodendrosis, plaque-like primary demyelination
and preservation of axons. These different types of lesions
may indicate how the pathology progresses or be a patho-
logical change accompanying other diseases, such as in is-
chaemic stroke. In acute haemorrhagic leukoencephalitis
(Robinson et al., 2014), there was early and widespread
astrocytic injury with swollen cell bodies and beaded pro-
cesses in the absence of demyelination, suggesting that de-
myelination is secondary to astrocyte injury, similar to that
in neuromyelitis optica and central pontine myelinolysis
(Misu et al., 2013; Popescu et al., 2013; Lucchinetti
et al., 2014).
We also found that although the total astrocyte popula-
tion in the frontal white matter was decreased, the numbers
of clasmatodendrocytes were increased in older age. This is
consistent with the fact that age per se is an important
contributor to the progression of white matter pathology
during brain ageing and relates to the increased white
matter hyperintensity volume (Inzitari et al., 2009).
The frontal white matter was more affected than the tem-
poral white matter in PSD patients, which possibly relates
to the frontal lobe being more vulnerable in cerebrovascu-
lar disease. Previous imaging and pathological studies have
suggested that the medullary arteries and white matter in
the frontal lobe are particularly susceptible to a haemo-
dynamic derangement, leading to much more severe white
matter damage than in the temporal lobe, during ageing
and vascular disease (Furuta et al., 1991; Ihara et al.,
2010). Tomimoto et al. (1996) demonstrated that there is
signiﬁcantly more ﬁbrinogen and immunoglobulins in
brains containing clasmatodendrosis than in brains with-
out, which suggested dysfunction of the blood–brain bar-
rier. In addition, the reduction of cerebral blood ﬂow and
cerebral perfusion was suggested to contribute to cognitive
impairment in chronic stroke patients (Mori et al., 1994).
We previously reported the association between the global
cerebral blood ﬂow in the grey matter/white matter ratio
and PSD (Firbank et al., 2011) and it is plausible that
blood ﬂow is a direct cause of clasmatodendrosis (Kraig
and Chesler, 1990; Qin et al., 2010).
Variations in clasmatodendrosis may also be inﬂuenced
by various factors. The degree of clasmatodendrosis
increased from the immediate subcortical layers toward
the deep white matter region, which may be due to a
staged response, possibly in relation to disease duration
or severity, or possibly a mixture of both. The differing
areas of clasmatodendrosis in patients suggests the vari-
ation in the extent of the stroke or a different response
to remote stroke lesions (Allan et al., 2011). Factors, such
as previous symptomatic stroke, previous asymptomatic
stroke seen on imaging, recurrent stroke, several stroke le-
sions, volume of the infarct and location of stroke, were
also associated with PSD (Pendlebury and Rothwell, 2009).
However, the experimental evidence showed that clasmato-
dendrosis occurs rather acutely after induction of cerebral
hypoperfusion in non-human primates suggesting that re-
current changes in perfusion pressure may constantly dis-
rupt gliovascular interactions, which progressively worsen
with ageing. Clasmatodendrosis of astrocytes can occur due
to a drop in tissue pH irrespective of the presence of gly-
colysis (Friede and van Houten, 1961). Therefore, it is ne-
cessary to distinguish normal tissue glycolysis from any
antemortem or post-mortem effects. We found no differ-
ences in the post-mortem delay times between samples
with mild and severe clasmatodendrosis, suggesting the dif-
ference in the severity of clasmatodendrosis between PSND
and PSD was an actual representation of astrocyte path-
ology. Furthermore, experimental evidence from perfused
ﬁxed baboon brains showed that similar clasmatodendrosis
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was associated with blood–brain barrier protein leakage
and abnormalities in the microvascular endothelium result-
ing from cerebral hypoperfusion. Furthermore, our ﬁndings
here are entirely consistent with the association of gliovas-
cular alterations and cognitive deﬁcits we reported earlier
(Holland et al., 2015) in a mouse model of sustained cere-
bral hypoperfusion with features of small vessel disease
(white matter disruption) induced by bilateral common ca-
rotid stenosis (BCAS) (Okamoto et al., 2012). In our BCAS
model, we showed that gliovascular changes revealed a
marked increase in microvessel diameter, vascular wall dis-
ruption, ﬁbrinoid necrosis, haemorrhage, and blood–brain
barrier alterations with widespread reactive gliosis, includ-
ing displacement of the astrocytic water channel, AQP4
(Holland et al., 2015). The gliovascular changes reported
in this model were more pronounced in the subcortical
thalamic regions but similar alterations occured in the
corpus callosum. Such spatial dissociation between the vas-
cular basement membrane and the astrocyte endfeet also
occurs in ischaemic brain in spontaneously hypertensive
rats with middle cerebral artery occlusion (MCAO)
(Yamashita et al., 2009). The basement membrane/extracel-
lular matrix linking the endothelial cells appear essential
for maintaining the integrity of the neuro- or gliovascular
unit, which is disrupted by tissue plasminogen activator
treatment.
The altered AQP4 distribution in the shrinking processes
and the swelling of astrocytic cell bodies relates to changes
in water mobility or the disturbance of water homeostasis
(Taniguchi et al., 2000). It may also affect the local micro-
circulation, since AQP4 is located predominantly at the end
foot and ependyma of astrocytes, which wrap around brain
microvessels (Badaut et al., 2002). AQP4 provides struc-
tural integrity to the cerebral vasculature (El-Khoury
et al., 2006) and also promotes water exchange between
blood and CSF in pathophysiological conditions. The oc-
currence of clasmatodendrosis in Alzheimer’s disease com-
bined with cerebrovascular disease but not in Alzheimer’s
disease without vascular pathology (Tomimoto et al.,
1996), indicates an involvement of vascular events in the
onset of clasmatodendrosis. It is expected that astrocyte
pathology is differentially involved in Alzheimer’s disease,
vascular dementia and mixed (Alzheimer’s disease and vas-
cular dementia) subjects and the severity of clasmatoden-
drosis may depend on the extent of cerebrovascular
pathology in these diseases.
Are astrocytes an early target before neuronal or axonal
damage in ischaemic injury? Astrocyte cultures from the
hippocampus (Hulse et al., 2001), after exposure to acidic
Ringer’s solution and mitochondrial inhibition, showed
that the greatest degree of clasmatodendrosis occurred in
the pyramidal cell body layers and closely paralleled that
seen in vivo (Friede and van Houten, 1961). Given
these observations, we cannot rule out that low level
clasmatodendrosis occurs in the pyramidal cell layers
of the cortex above the white matter in our cases and
together with white matter astrocyte pathology could
directly or indirectly causes neuronal damage, resulting in
cognitive dysfunction (Gemmell et al., 2012; Foster et al.,
2014).
We have provided clinical, pathological and experimental
evidence to support the interpretation of our ﬁndings on
how cognitive function in ageing subjects with greater vol-
umes of white matter hyperintensities may decline.
However, there are some limitations of the study. We
could not provide pathological data from all the post-
stroke survivors who had MRI in life but were only able
to analyse a sizeable sample as a proxy. We were also
limited in assessing blood–brain barrier or perfusion
changes in the white matter in vivo (Wardlaw et al.,
2009) to complement the pathological ﬁndings and show
directly that frontal lobe white matter perfusion is more
vulnerable in post-stroke survivors or those subjects with
cerebral small vessel disease who decline cognitively to de-
velop dementia.
In summary, our ﬁndings suggest a novel association be-
tween the irreversible astrocyte injury (clasmatodendrosis)
and PSD. This large aetiological study of clasmatodendrosis
after stroke enables us to understand more about the
pathophysiological substrates associated with brain
ageing, PSD and vascular dementia. The information
gained may also be invaluable in producing interventions
to reduce the rate of clasmatodendrosis, which in turn
could help to reduce the burden of dementia.
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